Keystone Financial Group
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1729299
LEXINGTON, KY
Position in RXRX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$36,700
-$12,420 QoQ
Shares Held
10,000
-37.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#268
of 340 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Keystone Financial Group holds $1,628,928 across 8 Biotechnology names. RXRX ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
8,000 | $652,080 | |
| 2 | PRME |
Prime Medicine, Inc.
|
166,510 | $614,421 | |
| 3 | CRBU |
Caribou Biosciences, Inc.
|
80,825 | $142,252 | |
| 4 | IBRX |
ImmunityBio, Inc.
|
10,000 | $87,550 | |
| 5 | EDIT |
Editas Medicine, Inc.
|
14,050 | $45,522 | |
| 6 | LRMR |
Larimar Therapeutics, Inc.
|
13,000 | $39,650 | |
| 7 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
10,000 | $36,700 | |
| 8 | BRTX |
BioRestorative Therapies, Inc.
|
28,600 | $10,753 |
All Filings in RXRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,700 | 10,000 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $49,120 | 16,000 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $57,260 | 14,000 | Shares | Sole | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||